Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in... see more

GREY:LXXGQ - Post Discussion

Lexagene Holdings Inc > RE: Lex stock about to take off guys!!!!!
View:
Post by letsdoit on May 28, 2020 8:12am

RE: Lex stock about to take off guys!!!!!

LexaGene Places a Pre-Commercial Instrument for COVID-19 Testing in a Major Hospital Laboratory

BEVERLY, Mass. – May 28, 2020 –  LexaGene Holdings, Inc., (TSX-V: LXGOTCQB: LXXGF) (the “Company”) a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, is pleased to announce the placing of a pre-commercial instrument that tests for COVID-19 and other respiratory pathogens at the Dartmouth-Hitchcock Medical Center (DHMC) in their Laboratory for Clinical Genomics and Advanced Technology (CGAT) in Hanover, New Hampshire. 

Dr. Gregory J. Tsongalis, PhD, HCLD, CC, Professor and Vice Chair for Research Director at CGAT comments, “Our standard test for SARS-CoV-2, the pathogen that causes COVID-19, takes about 7.5 hours.  Given the highly contagious nature of this virus, this is a long time to wait.  We want the ability to get results much faster and to be able to screen for more pathogens at once since respiratory symptoms can be caused by numerous other viruses.”

Dr. Jack Regan, LexaGene’s Founder and CEO, states, “We are excited to be able to contribute to the fight against COVID-19 and illustrate our applications in the human clinical space.  Unlike many of the near-patient testing solutions used today that only look for COVID-19 and have a significant false negative rate, the instrument we have placed at Dartmouth-Hitchcock screens for many pathogens at once, namely COVID-19, influenza, RSV, adenovirus, metapneumovirus, and seasonal coronavirus, and it performs gold-standard chemistry for exceptional data quality.  Our breadth of detection allows users of our technology to generate informative data for the vast majority of people with respiratory symptoms.  This is particularly important as healthcare providers are increasingly questioning negative results from COVID-19 only tests, wondering if the test result is a false negative or the person is sick from another pathogen.”

The Company is also pleased to report that we have submitted our plan to the FDA for Emergency Use Authorization (EUA) for COVID-19 testing and anticipates completing the described studies in the near future.  Until these studies are completed and the FDA grants LexaGene’s instrument EUA for COVID-19 testing, all work using LexaGene instruments is classified as Research Use Only and cannot be used for human clinical diagnostics.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.
 

On Behalf of the Board of Directors
Signed "Dr. Jack Regan"
Dr. Jack Regan, Chairman of the Board of Directors & Chief Executive Officer

Comment by Investor62 on May 28, 2020 8:36am
@letsdoit: are you now more convident that this is a real company and not a fake?
Comment by letsdoit on May 28, 2020 8:40am
I'm on my best behaviour for a 3 month period, this placement does give me a little bit more confidence, however, it is only for research purposes at this time, I will have full confidence as and when they start to actually sell product's, competing commercially is a whole different ball game entirely.
Comment by iamjunobaz on May 28, 2020 9:42am
I look forward to your apology unless of course you are still on the Hydroxichloriqine  Mr Blah Blah Blah So your saying they placed a commercial unit in a hospital for human Covid testing Huh! But I thought you said they didn't have any units and it's all fake news and DR is a conman  Please  Clarify Don
Comment by letsdoit on May 28, 2020 9:51am
a couple of things here, obviously you're not a very bright individual, it is not a commercial unit at all, it is a pre-commercial unit which is very different from a commercial unit, if you read it properly numbnut it categorically states it is for research purposes only, they have not sold a commercial unit AT ALL, and I need to clarify that DR is in fact a conman and that is according to ...more  
Comment by iamjunobaz on May 28, 2020 10:13am
Are you really as stoopid as you make out? It's a pre commercial commercial unit you thickwitt,it's the unit that will be commercialised. You don't think they put Frankenstein into a hospital do you ? They are using the data from the unit to get through FDA!!! Just think a little  The wording refers to trials in humans until such times they get FDA  This does not mean the ...more  
Comment by letsdoit on May 28, 2020 10:17am
ah I see, so, that's great news they've started selling commercial units, how much was the first sale for? any idea what the profit margin was on the first commercial sale, this is fantastic news, hey guys Lexagene have started trading, looking forward to the seeing the balance sheet, this is amazing
Comment by iamjunobaz on May 28, 2020 10:28am
You really are the most ignorant stupid Muppett on the planet  They are obviously trialing what is a commercial unit,you wouldn't use a cricket bat to get authority for a new golf driver to meet USPGA regs would you I didn't say they were selling anything,I said the unit being trialed will be as per the commercial units to be sold. They can't obtain FDA on a compliantly ...more  
Comment by Right80% on May 28, 2020 10:31am
He isn't what he says he is. He doesnt have a bunch of investments as he doesn't post on any other boards. He likely gets off on bugging people while hiding behind his keyboard.. The more we let him get to us the more he wins. I bet this is more exciting to him than watching porn in his moms basement. 
Comment by Right80% on May 28, 2020 10:24am
Don't bother wasting your time on him anymore. He doesn't have enough skin in the game to educate himself and likely lives in his mom's basememt. He's quite the relentless keyboard warrior though. Probably medicated or something. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities